X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES CADILA HEALTHCARE SUVEN LIFESCIENCES/
CADILA HEALTHCARE
 
P/E (TTM) x 21.3 12.9 164.7% View Chart
P/BV x 4.2 2.7 153.5% View Chart
Dividend Yield % 0.5 1.5 36.3%  

Financials

 SUVEN LIFESCIENCES   CADILA HEALTHCARE
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-18
CADILA HEALTHCARE
Mar-18
SUVEN LIFESCIENCES/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs251558 44.9%   
Low Rs155362 42.9%   
Sales per share (Unadj.) Rs49.1116.3 42.2%  
Earnings per share (Unadj.) Rs9.717.9 54.4%  
Cash flow per share (Unadj.) Rs11.423.1 49.2%  
Dividends per share (Unadj.) Rs1.503.50 42.9%  
Dividend yield (eoy) %0.70.8 97.1%  
Book value per share (Unadj.) Rs60.385.4 70.6%  
Shares outstanding (eoy) m127.281,023.74 12.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.14.0 104.5%   
Avg P/E ratio x20.925.7 81.1%  
P/CF ratio (eoy) x17.819.9 89.6%  
Price / Book Value ratio x3.45.4 62.5%  
Dividend payout %15.419.6 78.8%   
Avg Mkt Cap Rs m25,825470,664 5.5%   
No. of employees `0001.111.8 9.1%   
Total wages/salary Rs m61318,545 3.3%   
Avg. sales/employee Rs Th5,832.610,072.7 57.9%   
Avg. wages/employee Rs Th571.51,569.1 36.4%   
Avg. net profit/employee Rs Th1,153.81,547.7 74.5%   
INCOME DATA
Net Sales Rs m6,253119,049 5.3%  
Other income Rs m2331,132 20.6%   
Total revenues Rs m6,485120,181 5.4%   
Gross profit Rs m1,98228,475 7.0%  
Depreciation Rs m2135,388 4.0%   
Interest Rs m46911 5.1%   
Profit before tax Rs m1,95523,308 8.4%   
Minority Interest Rs m0628 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7185,644 12.7%   
Profit after tax Rs m1,23718,292 6.8%  
Gross profit margin %31.723.9 132.5%  
Effective tax rate %36.724.2 151.7%   
Net profit margin %19.815.4 128.7%  
BALANCE SHEET DATA
Current assets Rs m5,62282,005 6.9%   
Current liabilities Rs m1,16860,720 1.9%   
Net working cap to sales %71.217.9 398.5%  
Current ratio x4.81.4 356.5%  
Inventory Days Days8173 111.3%  
Debtors Days Days3698 36.5%  
Net fixed assets Rs m3,32583,703 4.0%   
Share capital Rs m1271,024 12.4%   
"Free" reserves Rs m7,54786,421 8.7%   
Net worth Rs m7,67487,445 8.8%   
Long term debt Rs m1425,551 0.1%   
Total assets Rs m9,135180,653 5.1%  
Interest coverage x43.226.6 162.6%   
Debt to equity ratio x00.3 0.6%  
Sales to assets ratio x0.70.7 103.9%   
Return on assets %14.010.6 132.1%  
Return on equity %16.120.9 77.0%  
Return on capital %26.022.0 118.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,06642,683 11.9%   
Fx outflow Rs m2,00111,242 17.8%   
Net fx Rs m3,06531,441 9.7%   
CASH FLOW
From Operations Rs m6999,193 7.6%  
From Investments Rs m-6-9,737 0.1%  
From Financial Activity Rs m-577515 -112.0%  
Net Cashflow Rs m116-29 -401.0%  

Share Holding

Indian Promoters % 63.4 74.8 84.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 8.3 -  
FIIs % 0.0 5.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 11.0 331.8%  
Shareholders   37,287 44,069 84.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   UNICHEM LAB  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare SUVEN LIFESCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Over 300 Points Higher; Energy and Metal Stocks Witness Buying(Closing)

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

7 Bluechips to Profit from Tech Disruption(Profit Hunter)

Jun 17, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Jun 25, 2019 03:37 PM

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS